title: Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
abstract: OBJECTIVE
  To examine whether impaired glucose tolerance and raised Lp(a) lipoprotein concentrations are associated in subjects with coronary artery disease.
  
  
  METHODS
  Study of two subject populations, one with and one without symptomatic coronary artery disease. Case-control analysis of patients with impaired glucose tolerance and normal glucose tolerance performed in each subject population independently.
  
  
  METHODS
  A general practice and a hospital ward in Newcastle upon Tyne.
  
  
  METHODS
  517 apparently healthy subjects, 13 with impaired glucose tolerance, and 245 patients who had undergone coronary artery bypass graft surgery 12 months before, 51 with impaired glucose tolerance.
  
  
  METHODS
  Serum Lp(a) lipoprotein concentration, plasma glucose concentration before and after oral challenge with 75 g glucose monohydrate, and Lp(a) lipoprotein isoforms.
  
  
  RESULTS
  In both the asymptomatic subjects and the subjects with coronary artery disease there was no significant difference between subjects with impaired glucose tolerance and subjects with normal and body mass index in serum Lp(a) lipoprotein concentrations (geometric mean 61 (geometric SD 4) mg/l v 83 (5) mg/l for asymptomatic subjects, 175 (3) v 197 (2) for subjects with heart disease), nor was there any difference in the proportion of subjects who had Lp(a) lipoprotein concentrations > 300 mg/l (31% v 23% for asymptomatic subjects, 37% v 37% for subjects with heart disease). For both subject groups there was no significant correlation between Lp(a) lipoprotein concentration and plasma glucose concentration after a glucose tolerance test, nor did Lp(a) lipoprotein concentration vary by quintile of glucose concentration after the test. Examination of Lp(a) lipoprotein isoforms in the subjects with coronary artery disease revealed an inverse relation between isoform size and plasma Lp(a) lipoprotein concentration, but there was no evidence that impaired glucose tolerance was associated with particular Lp(a) lipoprotein isoforms.
  
  
  CONCLUSIONS
  Raised Lp(a) lipoprotein concentrations are not responsible for the association between impaired glucose tolerance and coronary artery disease.
authors.affiliation: Department of Cardiology, Royal Victoria Infirmary, Newcastle upon Tyne.
authors.forename: M
authors.initials: M
authors.lastname: Farrer
authors.forename: F L
authors.initials: FL
authors.lastname: Game
authors.forename: C J
authors.initials: CJ
authors.lastname: Albers
authors.forename: H A
authors.initials: HA
authors.lastname: Neil
authors.forename: P H
authors.initials: PH
authors.lastname: Winocour
authors.forename: M F
authors.initials: MF
authors.lastname: Laker
authors.forename: P C
authors.initials: PC
authors.lastname: Adams
authors.forename: K G
authors.initials: KG
authors.lastname: Alberti
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D015992:Body Mass Index; D016022:Case-Control Studies; D003327:Coronary Disease / Q000378:metabolism*; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007536:Isomerism; D017270:Lipoprotein(a) / Q000737:chemistry / Q000378:metabolism*; D008297:Male; D008875:Middle Aged
chemical_list: D001786:Blood Glucose; D017270:Lipoprotein(a)